Financhill
Buy
64

TSHA Quote, Financials, Valuation and Earnings

Last price:
$5.05
Seasonality move :
-10.93%
Day range:
$5.01 - $5.24
52-week range:
$1.05 - $5.51
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
225.20x
P/B ratio:
6.32x
Volume:
3M
Avg. volume:
3.5M
1-year change:
112.18%
Market cap:
$1.4B
Revenue:
$8.3M
EPS (TTM):
-$0.35

Earnings Data

Next earnings date for TSHA
Feb 25
2026
Most recent earnings per share
-$0.09
Missed by $0.00
(Nov 4/2025)
Consensus Estimate
-$0.09
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TSHA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $1.9M -- -- -$0.10 --
11/04/2025 Q3 $1.4M -- -$0.09 -$0.09 -$0.00
08/12/2025 Q2 $1.6M $2M -$0.09 -$0.08 -$0.02
05/13/2025 Q1 $1.3M $2.3M -$0.08 -$0.09 $0.01
02/26/2025 Q4 $2.1M $2M -$0.09 -$0.10 $0.01
11/13/2024 Q3 $1.6M $1.8M -$0.10 -$0.09 -$0.01
08/12/2024 Q2 $2.6M $1.1M -$0.09 -$0.10 $0.01
05/14/2024 Q1 $2.3M $3.4M -$0.10 -$0.10 -$0.01
03/19/2024 Q4 $2.7M $3.6M $0.26 -$0.10 $0.35
11/14/2023 Q3 -- -- -$0.93 -$0.17 -$0.76
08/14/2023 Q2 -- -- -$0.38 -$0.31 -$0.07
05/11/2023 Q1 -- -- -$0.28 -$0.38 $0.10
03/28/2023 Q4 -- -- -$0.99 -$0.34 -$0.65
11/08/2022 Q3 -- -- -$0.64 -$0.82 $0.18
08/11/2022 Q2 -- -- -$0.84 -$1.06 $0.22
05/16/2022 Q1 -- -- -$1.31 -$1.11 -$0.21
03/31/2022 Q4 -- -- -$1.32 -$1.27 -$0.05
11/10/2021 Q3 -- -- -$1.35 -$1.09 -$0.26
08/16/2021 Q2 -- -- -$1.09 -$0.86 -$0.23
05/11/2021 Q1 -- -- -$0.87 -$0.65 -$0.22
03/03/2021 Q4 -- -- -$0.49 -$0.49 $0.01
11/12/2020 Q3 -- -- -$1.28 $0.07 -$1.35
06/30/2020 Q2 -- -- -$0.61 -- --
03/31/2020 Q1 -- -- -$0.36 -- --
12/31/2019 Q4 -- -- -$0.07 -- --

Taysha Gene Therapies, Inc. Earnings Questions

  • How Much did Taysha Gene Therapies, Inc. Generate in Revenue Last Quarter?

    Taysha Gene Therapies, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Taysha Gene Therapies, Inc. Beat Earnings Last Quarter?

    Taysha Gene Therapies, Inc. announced earnings per share of -$0.09 which represents a miss of analyst forecast a -$0.09 per share.

  • Is Taysha Gene Therapies, Inc. Profitable?

    Taysha Gene Therapies, Inc. reported -$286K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Taysha Gene Therapies, Inc. EPS Next Year?

    Taysha Gene Therapies, Inc.'s earnings are forecast to decrease from -$0.36 per share to -$0.34 per share next year representing a decrease of -5.7%.

  • When is Taysha Gene Therapies, Inc.'s Earnings Date?

    Taysha Gene Therapies, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
50
TGL alert for Dec 8

Treasure Global, Inc. [TGL] is up 31.68% over the past day.

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 45.78% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 8.15% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock